Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Breast Cancer Research and Treatment|March 23, 2016
Equivalence of MammaPrint array types in clinical trials and diagnosticsInès Beumer, Anke Witteveen, Leonie Delahaye, et al.Elife|October 5, 2020
A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancerHaojie Jin, Siying Wang, Esther A Zaal, et al.Cell Reports|September 15, 2015
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer DrugsAnirudh Prahallad, Guus J J E Heynen, Giovanni Germano, et al.Breast Cancer Research and Treatment|April 29, 2017
A breast cancer gene signature for indolent diseaseLeonie J M J Delahaye, Caroline A Drukker, Christa Dreezen, et al.The Journal of Pathology|August 29, 2012
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequencySun Tian, Paul Roepman, Vlad Popovici, et al.Biomarker Insights|December 17, 2016
Prognostic Value of MammaPrint® in Invasive Lobular Breast CancerInès J Beumer, Marion Persoon, Anke Witteveen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.Nature Medicine|May 30, 2018
SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivoSara Mainardi, Antonio Mulero-Sánchez, Anirudh Prahallad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohortBen S Wittner, Dennis C Sgroi, Paula D Ryan, et al.Breast Cancer Research : BCR|October 5, 2015
Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy responseEsther H Lips, Magali Michaut, Marlous Hoogstraat, et al.Pageof 8